Another important biological feature of CLL is the usage of a biased IGHV-D-J repertoire (the so-called “stereotyped” BCR) (9) in around one-third of cases, particularly in U-CLL patients, with important pathogenic and prognostic implications (15, 16). Here, BCR is linked to B-cell chronic lymphocytic leukemia.